By FNN Staff
root@fnn-online.com

Videos

  •      08:44 AM DSM Acquires Martek Biosciences for $1.1B
  • 08:39 AM Pfizer to recall about 19,000 bottles of Lipitor due to odor

    Pfizer has announced that it intends to recall one lot—, approximately 19,000 bottles—, of Lipitor 40 mg tablets distributed in the U.S. The recall stems from one customer report of an uncharacteristic odor related to the bottles in which these lots of Lipitor were packaged. The bottles were...

  • 08:39 AM Toyota fined again by Obama administration

    The Obama administration is fining Toyota Motor (TM) $32.425M in civil penalties, which is the maximum allowed by law, for failing to properly disclose what it knew about safety defects linked to recalls of millions of vehicles last year and this year, reports the Wall Street Journal. The...

  • 08:32 AM ConAgra Meets Q2 Expectations

    ConAgra (CAG) reported Q2 EPS of $0.45, vs. Street estimates of $0.45. Sales were $3.16 bln, vs. the analyst consensus of $3.13 bln on Thomson Reuters. For FY 2011, the company expects EPS to grow at a low-single-digit rate over FY 2010 results.
  • 08:27 AM AstraZeneca to Take $445M Charge in Q4

    Officials from AstraZeneca (NYSE:AZN) said in a statement Tuesday that the company has requested that the U.S. Food and Drug Administration withdraw its application for the approval of its motavizumab drug, used to treat respiratory infections in babies. Instead, AstraZeneca will take a $445...

  • 08:19 AM What's In The News: December 21st, 2010

    This is what's in the news for Tuesday, December 21st. the Wall Street Journal reports that The SEC is investigating Chinese companies listing on U.S. stock exchanges through reverse takeovers. The Wall Street Journal reports that Blackstone Group (BX) is finalizing a new $15 billion fund, one...

  • 08:13 AM Morning Market Snapshot: December 21st, 2010

    Good Morning. It's Tuesday, December 21, 2010. At this hour, U.S. equity futures are higher. Overseas, the Asian markets were mixed, while the European markets are up. AstraZeneca (AZN) discontinued further development of motavizumab for the prophylaxis of serious respiratory syncytial virus...

  • 05:08 PM Darden Restaurants Meets Q2 Estimates
  • 05:02 PM Adobe Systems Tops With Q4 Results, Guides for Q1 Above Stre

    Adobe Systems (ADBE) reports Q4 non-GAAP EPS of $0.56 compared to $0.39 a year earlier and topping the Thomson Reuters mean analyst estimate for $0.52. The company reports record revenue of $1.008 billion, compared to $757.3 million a year earlier. The Street looked for $988 million. For Q1,...

  • 04:56 PM Jabil Posts Better-than-Expected Results, Guidance

    Jabil Circuit (NYSE:JBL) reported Q1 EPS of $0.61, ahead of consensus estimates of $0.55 per share. Revenues for the quarter rose 32.3% year-over-year to $4.1 billion, topping consensus estimates of $3.96 billion. The company sees Q2 EPS of $0.49 to $0.53, vs. consensus estimates of $0.44 per...